Botanical species · safety record

Clematis recta

The EFSA Compendium of Botanicals holds 6 constituent measurements for Clematis recta. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Clematis recta L.

6Constituent measurements

0Safety records

4Cited sources

5Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 5 licensed products naming Clematis recta as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Aerial parts
Fresh aerial part collected at flowering time

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Corytuberine	Aerial part of plants	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Coumarins	Aerial part of plants	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier
Magnoflorine	Stem / stalk	Solvent extraction	—	Indirect Immunofluorescent Antibody test (IFAT)	No resolvable identifier
Magnoflorine	Roots and other underground parts	Solvent extraction	—	Indirect Immunofluorescent Antibody test (IFAT)	No resolvable identifier
Protoanemonin	Stem / stalk	Solvent extraction	96 Microgram/gram	HPLC with standard detection methods	No resolvable identifier
Tannic acid	Aerial part of plants	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Slavik, Jiri., Slavikova, Leonora. Quaternary isoquinoline alkaloids and some diterpenoid alkaloids in plants of the Czech Republic. Collection of Czechoslovak Chemical Communications, 1995, p. 1034-1041.
Chawla, Rakesh., Kumar, Suresh., Sharma, Anupam. Pharmacognostic standardization of Clematis erecta Linn. International Journal of Pharmacy and Pharmaceutical Sciences, 2012, p. 482-487.
Bonora, A., Dall'Olio, G., Bruni, A. Separation and quantitation of protoanemonin in Ranunculaceae by normal- and reversed-phase HPLC. Planta Medica, 1985, p. 364-367.
Slavik, Jiri., Bochorakova, Jitka., Slavikova, Leonora. Occurrence of magnoflorine and corytuberine in some wild or cultivated plants of Czechoslovakia. Collection of Czechoslovak Chemical Communications, 1987, p. 804-811.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature